Abstract | OBJECTIVE: To investigate the efficacy of distinctin in a neutropenic mouse model of staphylococcal sepsis. DESIGN: Prospective, randomized, and controlled animal study. SETTING: Research laboratory in a University Hospital. SUBJECTS: BALB/c male mice. INTERVENTIONS: MEASUREMENTS AND MAIN RESULTS: Lethality, bacterial growth in blood and peritoneum, spleen, liver, and mesenteric lymph nodes. RESULTS: All combined regimen showed lower lethality rates than singly treated-groups. Distinctin plus vancomycin or teicoplanin exerted the lowest lethality rate. All regimens were significantly superior to controls at reducing blood, spleen, peritoneum, liver and mesenteric lymph node complex bacterial burdens, whereas all combined treated groups were higher effective than singly treated groups. CONCLUSION:
|
Authors | Oscar Cirioni, Roberto Ghiselli, Fiorenza Orlando, Carmela Silvestri, Stefania De Luca, Anna Maria Salzano, Federico Mocchegiani, Vittorio Saba, Giorgio Scalise, Andrea Scaloni, Andrea Giacometti |
Journal | Critical care medicine
(Crit Care Med)
Vol. 36
Issue 9
Pg. 2629-33
(Sep 2008)
ISSN: 1530-0293 [Electronic] United States |
PMID | 18679116
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Amphibian Proteins
- Anti-Bacterial Agents
- Antimicrobial Cationic Peptides
- distinctin
|
Topics |
- Amphibian Proteins
(pharmacology)
- Animals
- Anti-Bacterial Agents
(pharmacology)
- Antimicrobial Cationic Peptides
(pharmacology)
- Anura
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Hemolysis
- Male
- Mice
- Mice, Inbred BALB C
- Microbial Sensitivity Tests
- Neutropenia
(complications, drug therapy)
- Random Allocation
- Sepsis
(complications, drug therapy, microbiology)
- Staphylococcal Infections
(complications, drug therapy, microbiology)
- Staphylococcus aureus
(drug effects, isolation & purification)
|